Yes, estrogen decreases with age, but the pattern is more complex than a simple, steady decline. During reproductive years, estrogen levels typically range between 100 and 250 pg/mL. After menopause, they drop to around 10 pg/mL, a fraction of their former levels. The timeline of that drop, and what it means for your body, depends on where you are in the process.
How the Ovaries Gradually Lose Output
Estrogen production is tied directly to the ovaries’ supply of follicles, the tiny fluid-filled sacs that release eggs each cycle. You’re born with your lifetime supply, and the count starts shrinking before you’re even born. Follicular loss begins in the womb and continues through childhood, puberty, and your entire reproductive life. Most follicles don’t mature into eggs. They simply degenerate in a process called atresia.
As you age, both the dormant reserve and the pool of actively growing follicles get smaller. During ovulatory cycles, the dominant follicle is the primary estrogen producer. Fewer growing follicles means less estrogen output. What’s notable is that estrogen production stays clinically adequate until relatively late in the depletion process. You can lose a significant portion of your ovarian reserve before you’d ever notice a hormonal shift. The aging of the cells surrounding each follicle (granulosa cells) may also impair their ability to produce estrogen efficiently, compounding the effect of sheer numbers.
Perimenopause: The Unpredictable Middle Phase
The transition to menopause doesn’t look like a clean downward slope. Perimenopause, which typically begins 5 to 10 years before your final period, is marked by dramatic hormonal swings. Estrogen can spike higher than normal one week and plunge the next, as the brain ramps up signaling hormones (FSH and LH) in an attempt to coax the remaining follicles into action. These wild fluctuations are what drive many of the symptoms people associate with “going through menopause”: hot flashes, sleep disruption, mood changes, and irregular periods.
After your final menstrual period, the pattern shifts. Estrogen settles into consistently low levels and stays there. The transition from chaotic highs and lows to a stable baseline is what distinguishes perimenopause from postmenopause, and it’s why the two stages often feel very different.
Where Estrogen Comes From After Menopause
Your ovaries aren’t the only source of estrogen, and production doesn’t hit absolute zero after menopause. The adrenal glands, which sit on top of your kidneys, become a particularly important source of sex steroids in postmenopausal life. They produce androgens (hormones typically associated with male biology) that get converted into a weaker form of estrogen called estrone in fat tissue, muscle, and other organs. Four years after the final menstrual period, median estrone levels still measure around 65 to 73 pg/mL, depending on the study population.
This peripheral conversion keeps a small but meaningful amount of estrogen circulating. It’s nowhere near enough to maintain premenopausal function, but it does mean the body retains some estrogen activity. Body fat percentage influences this conversion, which is one reason body composition changes around menopause have hormonal consequences in both directions.
What Low Estrogen Does to Blood Vessels
Estrogen plays a direct role in keeping arteries flexible and responsive. It triggers the release of nitric oxide, a molecule that relaxes blood vessel walls and promotes healthy blood flow. In postmenopausal women, the ability of arteries to dilate in response to blood flow drops by about 30% compared to premenopausal women. This happens because prolonged estrogen deprivation reduces the number of estrogen receptors on the cells lining blood vessels. With fewer receptors, the signaling chain that produces nitric oxide weakens, and vessels become stiffer.
Research on healthy women shows that estrogen receptor levels in blood vessel cells are about 33% lower in postmenopausal women compared to premenopausal women during the high-estrogen phase of their cycle. Even within a single menstrual cycle, receptor expression drops 30% when estrogen is naturally low. The relationship between these receptors, nitric oxide production, and artery function is strong and well-documented. This vascular shift is a key reason cardiovascular disease risk rises after menopause.
Skin and Collagen Loss
Estrogen helps maintain skin thickness and collagen, the structural protein that gives skin its firmness. The decline is steep early on: skin collagen drops by roughly 30% in the first five years after menopause. After that initial loss, it continues at a slower pace of about 2% per year for the next 15 years. This is why many women notice a visible change in skin texture, elasticity, and wound healing relatively quickly after menopause, even if other symptoms are mild.
Vaginal and Urinary Changes
The tissues of the vagina, vulva, and urinary tract are especially sensitive to estrogen. When levels fall, these tissues thin and lose moisture, a condition now referred to as genitourinary syndrome of menopause. Between 27% and 84% of postmenopausal women experience symptoms, with some estimates of vulvovaginal atrophy specifically reaching as high as 90%. Unlike hot flashes, which tend to improve over time, these changes are progressive. They don’t resolve on their own and often worsen the longer someone is postmenopausal.
Estrogen Decline in Men
Estrogen decreases with age in men too, though the mechanism is entirely different. Men produce most of their estrogen (about 85%) not from the testes but from the conversion of circulating androgens into estrogen by an enzyme called aromatase, which operates in fat, bone, and other tissues. Only about 15% comes directly from the testes. As testosterone levels fall with age, the raw material for estrogen conversion declines as well.
Interestingly, research on bone density in aging men has found that bone loss correlates more closely with declining estrogen than with declining testosterone. The ratio of estrogen to testosterone, sometimes used as an indirect marker of aromatase activity, tends to increase with age and is actually higher in men with healthier bones than in those with osteoporosis or fragility fractures. This suggests that the body’s ability to maintain estrogen production through conversion becomes increasingly important for skeletal health as men age.